1. 經長期處理 ANE 或 ANE 30-100K 的 Jurkat T 和 OECM-1 細胞,對 cisplatin 和 5-FU 的抗藥性以及對低氧的耐受性均增強。
2. 經長期處理ANE或ANE 30-100K的Jurkat T細胞,其peroxiredoxin-1的分 泌量增加。
3. 經 短 期 處 理 ANE 或 ANE 30-100K 的 正 常 口 腔 纖 維 母 細 胞 , 其 peroxiredoxin-1的表現量與分泌量增加。
4. 正常組織peroxiredoxin-1的表現集中在上皮細胞,但卻表現在絕大部分的 腫瘤細胞中。
5. 嚼食檳榔者的OSCC比未嚼食者表現更高量的peroxiredoxin-1。
6. Arecoline 與 ANE 30-100K 同時會在 Jurkat T 細胞中誘導 IL-6,而後 者則誘導 IL-12, IL-13, IL17A, GM-CSF 的表現,可能因而促成口腔中的 發炎反應。
7. 經長期處理 ANE 或 ANE 30-100K 的 Jurkat T 細胞,B7 與 FOXP3 蛋白 的表現無顯著的增加。
參考文獻
1. Chu NS. Cardivascular responses to betel chewing. J Formos Med Assoc.
1993;92(9):835-7.
2. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage.
Addict Biol. 2002;7:77–83.
3. Lu SY, Chang KW, Liu CJ, et al. Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis. 2006;27(6):1273-84.
4. Ko YC, Huang YL, Lee CH, et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med.
1995;24:450-3.
5. Chang MC, Wu HL, Lee JJ, et al. The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation. J Biol Chem. 2004;
279(49):50676-83.
6. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;7:477-92.
7. IARC. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 2004;85:1-334.
8. Lee CH, Ko YC, Huang HL, et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer. 2003;88(3):366-72.
9. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-906.
10.Arends MJ, Morris RG, Wyllie AH. The role of the endonuclease. Am J Pathol. 1990;136:593-608.
11.Vanden Berghe T, van Loo G, Saelens X, et al. Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death D omain Protein FADD. J Biol Chem. 2004;279(9):7925-33.
12.Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology. 1973;7(3):253-66.
13.Chang MC, Ho YS, Lee PH, et al. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells : association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis. 2001;22(9):1527-35.
14.Lin CC, Chang MC, Chang HH, et al. Areca nut-induced micronuclei and
cytokinesis failure in Chinese hamster ovary cells is related to reactive oxygen species production and actin filament deregulation. Environ Mol Mutagen. 2009;50(5):367-74.
15.Wang CC, Liu TY, Cheng CH, Jan TR. Involvement of the mitochondrion-dependent pathway and oxidative stress in the apoptosis of murine splenocytes induced by areca nut extract. Toxicol In Vitro.
2009;23(5):840-7.
16.Chang MC, Uang BJ, Wu HL, Lee JJ, Hahn LJ, Jeng JH. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol:
roles of glutathione and reactive oxygenspecies. Br J Pharmacol.
2002;135:619-30.
17.鄭詠之,檳榔子成份誘導細胞死亡方式的機制。嘉南藥理科技大學,
2010。
18.Lin MH, Hsieh WF, Chiang WF, et al. Autophagy induction by the 30-100kDa fraction of areca nut in both normal and malignant cells through reactive oxygen species. Oral Oncol. 2010;46:822-8.
19.Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002;27:421-29.
20.Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol Cell
Biol. 2005;6(6):505-10.
21.Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems.
Nat Rev Mol Cell Biol. 2001;2(3):211-6.
22.Inguscio V, Panzarini E, Dini L.Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy. Cells. 2012;1(3):464-91
23.Crighton D, Wilkinson S, O'Prey J, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 2006;126(1):121-34.
24.Rhee SG, Woo HA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H₂O₂, and protein chaperones. Antioxid Redox Signal. 2011;15(3):781-94.
25.Riddell JR, Wang XY, Minderman H, Gollnick SO. Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. J Immunol. 2010;184(2):1022-30.
26.Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal. 2005;7(5-6):768-77
27.Lu HH, Kao SY, Liu TY, et al. Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy. 2010;6(6):725-37.
28.LU B, Finn OJ. T-cell death and cancer immune tolerance. Cell Death Differ.
2008;15(1):70-9.
29.Chang MC, Wu HL, Lee JJ, etal. The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation. J Biol Chem.
2004;279:50676–83.
30.Chang LY, Wan HC, Lai YL, etal. Areca nut extracts increased expression of inflammatory cytokines,tumornecrosis factor- a, interleukin-1, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J Periodont Res.
2009;44:175–83.
31.Jeng JH, Wang YJ, Chiang BL, etal. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-a production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis. 2003; 24:1301-15.
32.Nishikawa H and Sakaguchi S. Regulatory T cells in tumor immunity. Int. J Cancer. 2010;127(4):759-67.
33.Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol. 2008;8(6):467–77.
附表與附圖
活率。(c) Jurkat T 與篩選的細胞經不同濃度的 5-FU ( 0、6.7、18.3、40 mM ) 刺激 24 小時後以 LDH 來測定細胞毒性。(d) OECM-1 與篩選的細胞經不同 濃度的 5-FU ( 0、5.6、12、40 mM ) 刺激 24 小時後以 XTT 來測定細胞存 活率。*:P < 0.05,**:P < 0.01。
(a) (b)
1.5 Jurkat T
ANE-s
1.5 Jurkat T
ANE-s
0.01,***:P < 0.001。
-actin 的 LC3-II/actin 之平均比值除以各自 Jurkat T 組的 LC3-II/actin 之平均比值±
SD 之柱狀圖。**:P < 0.01,***:P < 0.001。
(a) Supernatant
(b)
圖 4. Jurkat T 經 ANE 和 ANE 30-100K 長期篩選後,其條件培養液的蛋白質 表現圖譜
細胞培養於無血清的培養基下,之後收其條件培養液,利用二維電泳分析。
(a) 條件培養液( supernatant )的圖譜。取 ANE-s 和 30-100K-s 與 Jurkat T 比 較,選出表現較強的點。(b) 經由成大貴重儀器中心比對、定序得知此蛋白 質為 peroxidoxin-1。
(a)
(b) AN users
9926 9929 10031 10045 10048 0
9926 9929 10031 10045 10048 0
(c) Non-AN users
(a) CMT-415 中不同濃度的 ANE 30-100K 對 PRDX1 的誘導情形。(b) PRDX1 於檳榔使用者正常口腔與腫瘤組織中分布位置與表現區域(%)之統計結 果。(c) PRDX1 於非檳榔使用者口腔腫瘤組織分布的情況。(d)非檳榔使用 者與檳榔使用者口腔腫瘤組織 PRDX1 表現區域(%)之統計結果。*:P <
0.05,**:P < 0.01。Bar=200m。
Ju rk a t T A N E -s si -A N E -s -5 1 1 si -A N E -s -5 1 2 3 0 -1 0 0 K -s si -3 0 -1 0 0 K -s -5 1 1 si -3 0 -1 0 0 K -s -5 1 2
PRDX1
-actin
Ju rk a t T A N E -s si -A N E -s -5 1 1 si -A N E -s -5 1 2 3 0 -1 0 0 K -s si -3 0 -1 0 0 K -s -5 1 1 si -3 0 -1 0 0 K -s -5 1 2
PRDX1
-actin
圖 6. Jurkat T 長期篩選後,經不同 PRDX1 RNAi 構築的 lentivirus 感染後,
其 PRDX1 蛋白的表現情形
Jurkat T 經 ANE 和 ANE 30-100K 長期篩選後的細胞株,經不同序列 PRDX1 RNAi(PRDX1-511 及 PRDX1-512)構築的 lentivirus 感染後,以西方墨點 法偵測其 PRDX1 的蛋白表現。
圖 7. Jurkat T 經不同的檳榔子成分刺激所誘導之細胞激素
將 Jurkat T(control)以無血清培養基培養 24 小時後,再以 ANE 30-100K (30-100K)與arecoline(Are) IC25 的劑量以及利用 Con A (25μg/ml)處理細 胞 24 小時,取其培養液進行細胞激素套組分析。Con A:正控制組。
(a) (b)
Jurkat T ANE-s 30-100K-s FOXP3
GAPDH
Jurkat T ANE-s 30-100K-s B7-H1
GAPDH
Jurkat T ANE-s 30-100K-s 0.0
0.5 1.0 1.5
FOXP3(fold)
Jurkat T ANE-s 30-100K-s 0.0
表一、ANE 及 ANE 30-100K 對不同細胞的篩選濃度
0.033 0.016
30-100K
0.08 0.023
ANE
OECM-1 Jurkat T
0.033 0.016
30-100K
0.08 0.023
ANE
OECM-1 Jurkat T
單位: µg/ml
GATGAGACTTTGAGACTAGTT PRDX1-512 shRNA GCTTTCAGTGATAGGGCAGAA
PRDX1-511 shRNA
or
附圖 1. PRDX1 RNAi 構築的 lentivirus 圖譜